Form-10 & S-1 Registrations: Uplist-OTC:QB, $4,500,000-Cash-Infusion, HHSE $.045-$.10
HHSE FORM 10 REGISTRATION
* Detailed Document (40 - 60 Pages) Essential HHSE Stock Information
* Audited Financial Statements
* Descriptions, Potential Opportunities & Conflicts of Interest
* Filed with SEC & Stored on EDGAR
* After 60 Day Review, HHSE Becomes SEC-Compliant
* HHSE Uplists To Higher Stock Exchange OTC:QB
* ~ $.03
HHSE S-1 REGISTRATION
* Direct Stock Purchase (Accredited Investor Buy Directly From HHSE)
* Cash Infusion (Unlike Market Buys, Monies Go Directly To HHSE Coffers)
* 150% of the VWAP of the HHSE shares
* Significant Premium "ABOVE" Market
* $.045 - $.10
* Potential $4,500,000
* Accretion, NOT Dilution
* HHSE Treasury Available For Corporate Investment
1). FORM 10 REGISTRATION - The long-awaited filing of the company's registration statement is the first step in the company's overall new launch. Large funds and investors that have been hesitant (or prohibited) from supporting HHSE as a Pinksheet stock will now be able to invest in HHSE shares. Management anticipates that the act of filing the Form 10 could (and should) result in a PPS of $.03 or higher. The Form 10 may be filed in the next few weeks, and the impact to the HHSE share price might be seen immediately - even though the S.E.C. has 60-days to provide "comments" requiring the issuer's response.
4). S-1 REGISTRATION - HHSE has been in discussions with three significant parties that have expressed support of buying HHSE shares under a S-1 Shelf Registration (simultaneous with the Form 10, or almost immediately thereafter). As presently envisioned, the S-1 would be launched in January with a total potential sale of up to 90-mm HHSE shares made available, with a base price anticipated in the $.045 range, and going all the way up to $.10 for the final traunch of shares. HHSE anticipates raising about $4.5-mm in direct operating capital - while only diluting the total A/S by 10% or less. These direct funds will provide marketing support for MyFlix - as well as cash-flow flexibility for assisting with the development of the tent-pole Major Films and other ongoing operations. The anticipated buyers of the S-1 offering are long-term, strategic partners, and are not expected to sell any of their shares in the first year or two. The structure of the S-1 incentivizes earlier subscribers, as the price per share increases as the inventory of S-1 shares is diminished. The base price of the first traunch of S-1 shares is being established to be at a level estimated to start at 150% of the VWAP of the HHSE shares - which means that these new shareholders are buying equity at a significant premium "above" market. The S-1 Registration will be filed shortly after the Form 10, as the company will await any initial feedback and comments to the registration statement.
.gif)
HHSE
HHSE FORM 10 REGISTRATION
* Detailed Document (40 - 60 Pages) Essential HHSE Stock Information
* Audited Financial Statements
* Descriptions, Potential Opportunities & Conflicts of Interest
* Filed with SEC & Stored on EDGAR
* After 60 Day Review, HHSE Becomes SEC-Compliant
* HHSE Uplists To Higher Stock Exchange OTC:QB
* ~ $.03
HHSE S-1 REGISTRATION
* Direct Stock Purchase (Accredited Investor Buy Directly From HHSE)
* Cash Infusion (Unlike Market Buys, Monies Go Directly To HHSE Coffers)
* 150% of the VWAP of the HHSE shares
* Significant Premium "ABOVE" Market
* $.045 - $.10
* Potential $4,500,000
* Accretion, NOT Dilution
* HHSE Treasury Available For Corporate Investment
1). FORM 10 REGISTRATION - The long-awaited filing of the company's registration statement is the first step in the company's overall new launch. Large funds and investors that have been hesitant (or prohibited) from supporting HHSE as a Pinksheet stock will now be able to invest in HHSE shares. Management anticipates that the act of filing the Form 10 could (and should) result in a PPS of $.03 or higher. The Form 10 may be filed in the next few weeks, and the impact to the HHSE share price might be seen immediately - even though the S.E.C. has 60-days to provide "comments" requiring the issuer's response.
4). S-1 REGISTRATION - HHSE has been in discussions with three significant parties that have expressed support of buying HHSE shares under a S-1 Shelf Registration (simultaneous with the Form 10, or almost immediately thereafter). As presently envisioned, the S-1 would be launched in January with a total potential sale of up to 90-mm HHSE shares made available, with a base price anticipated in the $.045 range, and going all the way up to $.10 for the final traunch of shares. HHSE anticipates raising about $4.5-mm in direct operating capital - while only diluting the total A/S by 10% or less. These direct funds will provide marketing support for MyFlix - as well as cash-flow flexibility for assisting with the development of the tent-pole Major Films and other ongoing operations. The anticipated buyers of the S-1 offering are long-term, strategic partners, and are not expected to sell any of their shares in the first year or two. The structure of the S-1 incentivizes earlier subscribers, as the price per share increases as the inventory of S-1 shares is diminished. The base price of the first traunch of S-1 shares is being established to be at a level estimated to start at 150% of the VWAP of the HHSE shares - which means that these new shareholders are buying equity at a significant premium "above" market. The S-1 Registration will be filed shortly after the Form 10, as the company will await any initial feedback and comments to the registration statement.
HHSE
